Diego Tosi

7PUBLICATIONS
69CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2026
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study.

Yonina R Murciano-Goroff, Antoine Hollebecque, Rebecca S Heist

|Oct 02, 2025
Accepting to Participate in an Early-Phase Clinical Trial in Oncology: A Qualitative Study on the Patients' Experiences, Understanding, and Inner Motivations.

Estelle Guerdoux, Anne Stoebner, Louise Coutant

|Oct 01, 2025
Targeting SUV4-20H Epigenetic Enzymes Enhances Topoisomerase II Poisoning in Prostate Cancer.

Fatima Alhourani, Marine Tauziet, Margaux Ayeul

|Apr 08, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.

Olivier Trédan, Damien Pouessel, Nicolas Penel

|Mar 26, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice.

Alexandra Fauvre, Chiara Ursino, Veronique Garambois

|Aug 31, 2023
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).

Alexandra Drakaki, Thomas Powles, Aristotelis Bamias

Pageof 2

Frequent Collaborators

2 joint publications

Carlos Gomez-Roca

2 joint publications

Philippe Cassier

2 joint publications

Céline Gongora

1 joint publications

Alexandra Drakaki